Global IBS Treatment Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 118

Report ID: 6688

Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.

The global IBS Treatment market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on IBS Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall IBS Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Allergan Plc (Ireland)
Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals, Inc. (U.S.)
Astellas Pharma Inc. (Japan)
Valeant Pharmaceuticals (Canada)
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals, Inc. (U.S.)
Ardelyx, Inc. (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA, Inc. (Italy)
RedHill Biopharma Ltd. (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Ltd (Japan)
Synthetic Biologics, Inc. (U.S.)
Protagonist Therapeutics Inc. (U.S.)
Pfizer Inc (U.S.)
Lexicon Pharmaceuticals, Inc. (U.S.)
Innovate Biopharmaceuticals (U.S.)

Segment by Regions
North America
Europe
China
Japan

Segment by Type
By Types
IBS-D
IBS-C
IBS-M
By Drugs Type
Lubiprostone
Linaclotide
Eluxadoline
Rifaximin
Alosetron
Others

Segment by Application
Hospitals
Clinics
Research Laboratories

Table of Contents

Executive Summary
1 IBS Treatment Market Overview
1.1 Product Overview and Scope of IBS Treatment
1.2 IBS Treatment Segment By Types
1.2.1 Global IBS Treatment Production Growth Rate Comparison By Types (2014-2025)
1.2.2 IBS-D
1.2.3 IBS-C
1.2.4 IBS-M
1.3 IBS Treatment Segment by Application
1.3.1 IBS Treatment Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Laboratories
1.4 Global IBS Treatment Market by Region
1.4.1 Global IBS Treatment Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.4.6 Southeast Asia Status and Prospect (2014-2025)
1.4.7 India Status and Prospect (2014-2025)
1.5 Global IBS Treatment Market Size
1.5.1 Global IBS Treatment Revenue (2014-2025)
1.5.2 Global IBS Treatment Production (2014-2025)

2 Global IBS Treatment Market Competition by Manufacturers
2.1 Global IBS Treatment Production Market Share by Manufacturers (2014-2019)
2.2 Global IBS Treatment Revenue Share by Manufacturers (2014-2019)
2.3 Global IBS Treatment Average Price by Manufacturers (2014-2019)
2.4 Manufacturers IBS Treatment Production Sites, Area Served, Product Types
2.5 IBS Treatment Market Competitive Situation and Trends
2.5.1 IBS Treatment Market Concentration Rate
2.5.2 IBS Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global IBS Treatment Production Market Share by Regions
3.1 Global IBS Treatment Production Market Share by Regions
3.2 Global IBS Treatment Revenue Market Share by Regions (2014-2019)
3.3 Global IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America IBS Treatment Production
3.4.1 North America IBS Treatment Production Growth Rate (2014-2019)
3.4.2 North America IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe IBS Treatment Production
3.5.1 Europe IBS Treatment Production Growth Rate (2014-2019)
3.5.2 Europe IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China IBS Treatment Production (2014-2019)
3.6.1 China IBS Treatment Production Growth Rate (2014-2019)
3.6.2 China IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan IBS Treatment Production (2014-2019)
3.7.1 Japan IBS Treatment Production Growth Rate (2014-2019)
3.7.2 Japan IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)

4 Global IBS Treatment Consumption by Regions
4.1 Global IBS Treatment Consumption by Regions
4.2 North America IBS Treatment Consumption (2014-2019)
4.3 Europe IBS Treatment Consumption (2014-2019)
4.4 China IBS Treatment Consumption (2014-2019)
4.5 Japan IBS Treatment Consumption (2014-2019)

5 Global IBS Treatment Production, Revenue, Price Trend by Type
5.1 Global IBS Treatment Production Market Share by Type (2014-2019)
5.2 Global IBS Treatment Revenue Market Share by Type (2014-2019)
5.3 Global IBS Treatment Price by Type (2014-2019)
5.4 Global IBS Treatment Production Growth by Type (2014-2019)

6 Global IBS Treatment Market Analysis by Applications
6.1 Global IBS Treatment Consumption Market Share by Application (2014-2019)
6.2 Global IBS Treatment Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in IBS Treatment Business
7.1 Allergan Plc (Ireland)
7.1.1 Allergan Plc (Ireland) IBS Treatment Production Sites and Area Served
7.1.2 IBS Treatment Product Introduction, Application and Specification
7.1.3 Allergan Plc (Ireland) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Sucampo Pharmaceuticals (U.S.)
7.2.1 Sucampo Pharmaceuticals (U.S.) IBS Treatment Production Sites and Area Served
7.2.2 IBS Treatment Product Introduction, Application and Specification
7.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Ironwood Pharmaceuticals, Inc. (U.S.)
7.3.1 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Production Sites and Area Served
7.3.2 IBS Treatment Product Introduction, Application and Specification
7.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Astellas Pharma Inc. (Japan)
7.4.1 Astellas Pharma Inc. (Japan) IBS Treatment Production Sites and Area Served
7.4.2 IBS Treatment Product Introduction, Application and Specification
7.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Valeant Pharmaceuticals (Canada)
7.5.1 Valeant Pharmaceuticals (Canada) IBS Treatment Production Sites and Area Served
7.5.2 IBS Treatment Product Introduction, Application and Specification
7.5.3 Valeant Pharmaceuticals (Canada) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Abbott Laboratories (U.S.)
7.6.1 Abbott Laboratories (U.S.) IBS Treatment Production Sites and Area Served
7.6.2 IBS Treatment Product Introduction, Application and Specification
7.6.3 Abbott Laboratories (U.S.) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Synergy Pharmaceuticals, Inc. (U.S.)
7.7.1 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Production Sites and Area Served
7.7.2 IBS Treatment Product Introduction, Application and Specification
7.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Ardelyx, Inc. (U.S.)
7.8.1 Ardelyx, Inc. (U.S.) IBS Treatment Production Sites and Area Served
7.8.2 IBS Treatment Product Introduction, Application and Specification
7.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Nestle (Switzerland)
7.9.1 Nestle (Switzerland) IBS Treatment Production Sites and Area Served
7.9.2 IBS Treatment Product Introduction, Application and Specification
7.9.3 Nestle (Switzerland) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Sebela Pharmaceuticals (Ireland)
7.10.1 Sebela Pharmaceuticals (Ireland) IBS Treatment Production Sites and Area Served
7.10.2 IBS Treatment Product Introduction, Application and Specification
7.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Probi (Sweden)
7.12 Alfasigma USA, Inc. (Italy)
7.13 RedHill Biopharma Ltd. (Israel)
7.14 AstraZeneca (U.K)
7.15 Ipsen (France)
7.16 Novartis AG (Switzerland)
7.17 Takeda Pharmaceutical Company Ltd (Japan)
7.18 Synthetic Biologics, Inc. (U.S.)
7.19 Protagonist Therapeutics Inc. (U.S.)
7.20 Pfizer Inc (U.S.)
7.21 Lexicon Pharmaceuticals, Inc. (U.S.)
7.22 Innovate Biopharmaceuticals (U.S.)

8 IBS Treatment Manufacturing Cost Analysis
8.1 IBS Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of IBS Treatment
8.4 IBS Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 IBS Treatment Distributors List
9.3 IBS Treatment Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global IBS Treatment Market Forecast
11.1 Global IBS Treatment Production, Revenue Forecast
11.1.1 Global IBS Treatment Production Growth Rate Forecast (2019-2025)
11.1.2 Global IBS Treatment Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global IBS Treatment Price and Trend Forecast (2019-2025)
11.2 Global IBS Treatment Production Forecast by Regions (2019-2025)
11.2.1 North America IBS Treatment Production, Revenue Forecast (2019-2025)
11.2.2 Europe IBS Treatment Production, Revenue Forecast (2019-2025)
11.2.3 China IBS Treatment Production, Revenue Forecast (2019-2025)
11.2.4 Japan IBS Treatment Production, Revenue Forecast (2019-2025)
11.3 Global IBS Treatment Consumption Forecast by Regions (2019-2025)
11.3.1 North America IBS Treatment Consumption Forecast (2019-2025)
11.3.2 Europe IBS Treatment Consumption Forecast (2019-2025)
11.3.3 China IBS Treatment Consumption Forecast (2019-2025)
11.3.4 Japan IBS Treatment Consumption Forecast (2019-2025)
11.4 Global IBS Treatment Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global IBS Treatment Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer